Terms call for Enovix to receive $385 million in net cash, after expenses consisting of approximately $230 million cash held in trust by the SPAC and a $175 million concurrent PIPE of common stock issued at $14 per share.
The combined company will have an implied pro forma enterprise value of approximately $1.4 billion and is expected to have an equity value of $1.8 billion at closing.